SCHEMBL20172629

SCHEMBL20172629

C=C(/C=C\C)N(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.42
▸ PHGDH O43175 1/20 0.42
▸ MGLL Q99685 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNB4 P30926 1/20 0.35
▸ CHRNA3 P32297 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HTT P42858 2/20 0.34
▸ EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29304969 0.89 MEN1 (0.37) FAAHPHGDHMGLLCA12CA1
SCHEMBL24411467 0.87 FAAH (0.39) FAAHPHGDHMGLLCA12CA1
SCHEMBL23652017 0.82 MEN1 (0.34) FAAHPHGDHMGLLCA12CA1
SCHEMBL22053528 0.81 FAAH (0.40) FAAHPHGDHMGLLCA12CA1
SCHEMBL22053587 0.79 FAAH (0.39) FAAHPHGDHMGLLCA12CA1
SCHEMBL21913825 0.79 FAAH (0.39) FAAHPHGDHMGLLCA12CA1
SCHEMBL25630960 0.79 FAAH (0.45) FAAHPHGDHMGLLCA12CA1
SCHEMBL22478894 0.78 KMT2A (0.40) FAAHPHGDHMGLLCA12CA1
SCHEMBL19174613 0.78 FAAH (0.44) FAAHPHGDHMGLLCA12CA1
SCHEMBL9723822 0.78 FAAH (0.48) FAAHPHGDHMGLLCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210184149-A1 FILM PRODUCTION METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-17 — — US disclosed
EP-3361521-B1 LIGHT-EMITTING ELEMENT SUMITOMO CHEMICAL CO (JP) 2021-03-10 — — EP disclosed
WO-2020109434-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-06-04 — — WO disclosed
US-20190221744-A1 LIGHT EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-18 — — US disclosed
US-20190031673-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2019-01-31 — — US disclosed
WO-2018117562-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 2018-06-28 — — WO disclosed
EP-2551932-B1 Host materials for phosphorescent oleds UNIVERSAL DISPLAY CORP (US) 2018-05-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031673-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device NDUFC1, ARNT, NFE2L2 FAAH 3160/4885PHGDH 3800/4885MGLL 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback